Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2017 1
2018 1
2019 1
2021 2
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
New voices for a better society.
Diem SJ, Bayon BL, Mahmoud H, Garcia-Cazarin ML, Martin MJ, Rittschof CC, Silveyra P, Boland-Reeves A, Najib D, Wasson F. Diem SJ, et al. Among authors: najib d. Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2404579121. doi: 10.1073/pnas.2404579121. Epub 2024 Apr 24. Proc Natl Acad Sci U S A. 2024. PMID: 38657043 Free PMC article. No abstract available.
COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.
Demelo-Rodriguez P, Alonso-Beato R, Jara-Palomares L, Galeano-Valle F, Bura-Riviere A, Visonà A, Francisco I, Vidal G, López-Ruiz A, Monreal M; RIETE Investigators. Demelo-Rodriguez P, et al. Res Pract Thromb Haemost. 2023 Sep 20;7(7):102206. doi: 10.1016/j.rpth.2023.102206. eCollection 2023 Oct. Res Pract Thromb Haemost. 2023. PMID: 37840687 Free PMC article.
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations.
Mora D, Mateo J, Nieto JA, Bikdeli B, Yamashita Y, Barco S, Jimenez D, Demelo-Rodriguez P, Rosa V, Yoo HHB, Sadeghipour P, Monreal M; Registro Informatizado de Enfermedad TromboEmbólica (RIETE) Investigators. Mora D, et al. Br J Haematol. 2023 Jun;201(5):971-981. doi: 10.1111/bjh.18737. Epub 2023 Mar 21. Br J Haematol. 2023. PMID: 36942630
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.
Mian AA, Haberbosch I, Khamaisie H, Agbarya A, Pietsch L, Eshel E, Najib D, Chiriches C, Ottmann OG, Hantschel O, Biondi RM, Ruthardt M, Mahajna J. Mian AA, et al. Among authors: najib d. Ann Hematol. 2021 Aug;100(8):2023-2029. doi: 10.1007/s00277-020-04357-z. Epub 2021 Jun 10. Ann Hematol. 2021. PMID: 34110462 Free PMC article.
14 results